annual SGA:
$96.82M+$5.89M(+6.48%)Summary
- As of today (May 29, 2025), ARWR annual SGA is $96.82 million, with the most recent change of +$5.89 million (+6.48%) on September 30, 2024.
- During the last 3 years, ARWR annual SGA has risen by +$15.84 million (+19.56%).
- ARWR annual SGA is now -22.19% below its all-time high of $124.43 million, reached on September 30, 2022.
Performance
ARWR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$27.89M+$1.49M(+5.66%)Summary
- As of today (May 29, 2025), ARWR quarterly SGA is $27.89 million, with the most recent change of +$1.49 million (+5.66%) on March 31, 2025.
- Over the past year, ARWR quarterly SGA has increased by +$3.25 million (+13.19%).
- ARWR quarterly SGA is now -27.14% below its all-time high of $38.29 million, reached on September 30, 2021.
Performance
ARWR quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$6.31B-$143.97M(-2.34%)Summary
- As of today (May 29, 2025), ARWR TTM SGA is -$6.31 billion, with the most recent change of -$143.97 million (-2.34%) on March 31, 2025.
- Over the past year, ARWR TTM SGA has dropped by -$6.40 billion (-6713.42%).
- ARWR TTM SGA is now -317055.98% below its all-time high of -$1.99 million.
Performance
ARWR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ARWR Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +6.5% | +13.2% | -6713.4% |
3 y3 years | +19.6% | -17.6% | -5603.8% |
5 y5 years | +264.6% | +72.5% | -10000.0% |
ARWR Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -22.2% | +19.6% | -17.6% | +35.5% | -142.9% | at low |
5 y | 5-year | -22.2% | +264.6% | -27.1% | +222.6% | -268.0% | at low |
alltime | all time | -22.2% | >+9999.0% | -27.1% | +751.6% | <-9999.0% | at low |
ARWR Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $27.89M(+5.7%) | $103.28M(+3.2%) |
Dec 2024 | - | $26.40M(+2.4%) | $100.03M(+3.3%) |
Sep 2024 | $96.82M(+6.5%) | $25.79M(+11.2%) | $96.82M(+1.7%) |
Jun 2024 | - | $23.20M(-5.9%) | $95.20M(-0.2%) |
Mar 2024 | - | $24.64M(+6.3%) | $95.37M(+2.0%) |
Dec 2023 | - | $23.19M(-4.0%) | $93.54M(+2.9%) |
Sep 2023 | $90.93M(-26.9%) | $24.17M(+3.4%) | $90.93M(-9.1%) |
Jun 2023 | - | $23.37M(+2.4%) | $100.00M(-8.6%) |
Mar 2023 | - | $22.82M(+10.9%) | $109.37M(-9.2%) |
Dec 2022 | - | $20.58M(-38.1%) | $120.42M(-3.2%) |
Sep 2022 | $124.43M(+53.7%) | $33.24M(+1.5%) | $124.43M(-3.9%) |
Jun 2022 | - | $32.74M(-3.3%) | $129.48M(+13.0%) |
Mar 2022 | - | $33.86M(+37.7%) | $114.60M(+18.2%) |
Dec 2021 | - | $24.59M(-35.8%) | $96.93M(+19.7%) |
Sep 2021 | $80.98M(+54.9%) | $38.29M(+114.4%) | $80.98M(+41.0%) |
Jun 2021 | - | $17.86M(+10.3%) | $57.42M(+14.5%) |
Mar 2021 | - | $16.19M(+87.2%) | $50.16M(+0.0%) |
Dec 2020 | - | $8.65M(-41.3%) | $50.14M(-4.1%) |
Sep 2020 | $52.28M(+96.9%) | $14.72M(+39.0%) | $52.28M(+9.3%) |
Jun 2020 | - | $10.60M(-34.5%) | $47.82M(+13.8%) |
Mar 2020 | - | $16.17M(+49.9%) | $42.04M(+34.7%) |
Dec 2019 | - | $10.79M(+5.0%) | $31.20M(+17.5%) |
Sep 2019 | $26.56M(+39.0%) | $10.27M(+113.5%) | $26.55M(+16.9%) |
Jun 2019 | - | $4.81M(-9.9%) | $22.71M(+1.0%) |
Mar 2019 | - | $5.34M(-13.0%) | $22.50M(+8.0%) |
Dec 2018 | - | $6.13M(-4.6%) | $20.83M(+9.1%) |
Sep 2018 | $19.11M(+9.2%) | $6.43M(+40.0%) | $19.09M(+5.6%) |
Jun 2018 | - | $4.59M(+25.1%) | $18.09M(+3.9%) |
Mar 2018 | - | $3.67M(-16.4%) | $17.41M(-0.0%) |
Dec 2017 | - | $4.40M(-18.9%) | $17.42M(-19.3%) |
Sep 2017 | $17.50M(-25.8%) | $5.42M(+38.3%) | $21.57M(+81.7%) |
Jun 2017 | - | $3.92M(+6.6%) | $11.87M(-30.5%) |
Mar 2017 | - | $3.68M(-57.0%) | $17.09M(-28.5%) |
Dec 2016 | - | $8.55M(-299.9%) | $23.90M(+1.3%) |
Sep 2016 | $23.59M(-32.0%) | -$4.28M(-146.8%) | $23.59M(-41.0%) |
Jun 2016 | - | $9.14M(-12.8%) | $40.01M(+3.2%) |
Mar 2016 | - | $10.48M(+27.0%) | $38.76M(+8.5%) |
Dec 2015 | - | $8.25M(-32.0%) | $35.72M(+2.9%) |
Sep 2015 | $34.72M(+42.2%) | $12.14M(+53.9%) | $34.72M(+9.4%) |
Jun 2015 | - | $7.89M(+5.9%) | $31.74M(+6.0%) |
Mar 2015 | - | $7.44M(+2.6%) | $29.93M(+6.4%) |
Dec 2014 | - | $7.25M(-20.8%) | $28.13M(+15.3%) |
Sep 2014 | $24.42M(+108.8%) | $9.16M(+50.8%) | $24.40M(+34.0%) |
Jun 2014 | - | $6.08M(+7.6%) | $18.21M(+21.0%) |
Mar 2014 | - | $5.64M(+60.5%) | $15.05M(+22.7%) |
Dec 2013 | - | $3.52M(+18.2%) | $12.27M(+4.9%) |
Sep 2013 | $11.69M(-17.0%) | $2.97M(+2.1%) | $11.69M(+0.4%) |
Jun 2013 | - | $2.92M(+1.9%) | $11.65M(-16.4%) |
Mar 2013 | - | $2.86M(-2.8%) | $13.94M(-1.8%) |
Dec 2012 | - | $2.94M(+0.4%) | $14.20M(+0.7%) |
Sep 2012 | $14.10M | $2.93M(-43.7%) | $14.10M(+4.4%) |
Jun 2012 | - | $5.21M(+67.1%) | $13.50M(+40.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | $3.12M(+9.8%) | $9.63M(+18.7%) |
Dec 2011 | - | $2.84M(+21.4%) | $8.12M(+23.2%) |
Sep 2011 | $6.58M(+80.9%) | $2.34M(+74.7%) | $6.59M(+49.9%) |
Jun 2011 | - | $1.34M(-16.5%) | $4.39M(+3.1%) |
Mar 2011 | - | $1.60M(+22.4%) | $4.26M(+13.0%) |
Dec 2010 | - | $1.31M(+813.9%) | $3.77M(-14.5%) |
Sep 2010 | $3.64M(-74.1%) | $143.30K(-88.1%) | $4.41M(-35.8%) |
Jun 2010 | - | $1.21M(+8.6%) | $6.88M(-14.0%) |
Mar 2010 | - | $1.11M(-43.0%) | $8.00M(-25.2%) |
Dec 2009 | - | $1.95M(-25.1%) | $10.69M(-23.9%) |
Sep 2009 | $14.04M(-40.9%) | $2.61M(+11.9%) | $14.04M(-22.4%) |
Jun 2009 | - | $2.33M(-38.8%) | $18.09M(-18.8%) |
Mar 2009 | - | $3.80M(-28.2%) | $22.28M(-7.5%) |
Dec 2008 | - | $5.30M(-20.3%) | $24.09M(+0.5%) |
Sep 2008 | $23.75M(+39.0%) | $6.65M(+2.0%) | $23.98M(+5.9%) |
Jun 2008 | - | $6.52M(+16.1%) | $22.65M(+7.2%) |
Mar 2008 | - | $5.61M(+8.1%) | $21.14M(+9.0%) |
Dec 2007 | - | $5.19M(-2.5%) | $19.39M(+13.5%) |
Sep 2007 | $17.09M(+46.7%) | $5.33M(+6.4%) | $17.09M(+19.4%) |
Jun 2007 | - | $5.00M(+29.5%) | $14.31M(+10.5%) |
Mar 2007 | - | $3.86M(+33.5%) | $12.96M(+8.8%) |
Dec 2006 | - | $2.89M(+13.3%) | $11.91M(+10.9%) |
Sep 2006 | $11.65M(+86.5%) | $2.55M(-30.0%) | $10.74M(+3.8%) |
Jun 2006 | - | $3.65M(+29.7%) | $10.34M(+24.2%) |
Mar 2006 | - | $2.81M(+63.3%) | $8.33M(+22.1%) |
Dec 2005 | - | $1.72M(-20.2%) | $6.82M(+9.2%) |
Sep 2005 | $6.25M(+198.4%) | $2.16M(+32.2%) | $6.25M(+17.7%) |
Jun 2005 | - | $1.63M(+25.1%) | $5.31M(+30.2%) |
Mar 2005 | - | $1.31M(+13.6%) | $4.08M(+29.0%) |
Dec 2004 | - | $1.15M(-5.8%) | $3.16M(+51.0%) |
Sep 2004 | $2.09M(+2198.4%) | $1.22M(+204.3%) | $2.09M(+136.7%) |
Jun 2004 | - | $401.00K(+2.9%) | $884.30K(+77.4%) |
Mar 2004 | - | $389.80K(+376.5%) | $498.60K(+258.4%) |
Dec 2003 | - | $81.80K(+599.1%) | $139.10K(+52.7%) |
Sep 2003 | $91.10K(-36.6%) | $11.70K(-23.5%) | $91.10K(-26.6%) |
Jun 2003 | - | $15.30K(-49.5%) | $124.10K(-21.4%) |
Mar 2003 | - | $30.30K(-10.4%) | $157.90K(+4.8%) |
Dec 2002 | - | $33.80K(-24.4%) | $150.60K(+4.7%) |
Sep 2002 | $143.80K(+31.6%) | $44.70K(-9.0%) | $143.80K(+16.2%) |
Jun 2002 | - | $49.10K(+113.5%) | $123.70K(+32.6%) |
Mar 2002 | - | $23.00K(-14.8%) | $93.30K(-2.7%) |
Dec 2001 | - | $27.00K(+9.8%) | $95.90K(-12.3%) |
Sep 2001 | $109.30K(-17.2%) | $24.60K(+31.6%) | $109.30K(-8.5%) |
Jun 2001 | - | $18.70K(-27.0%) | $119.40K(-7.1%) |
Mar 2001 | - | $25.60K(-36.6%) | $128.50K(-4.7%) |
Dec 2000 | - | $40.40K(+16.4%) | $134.80K(+2.0%) |
Sep 2000 | $132.00K(+46.0%) | $34.70K(+24.8%) | $132.10K(+35.6%) |
Jun 2000 | - | $27.80K(-12.9%) | $97.40K(+39.9%) |
Mar 2000 | - | $31.90K(-15.4%) | $69.60K(+84.6%) |
Dec 1999 | - | $37.70K | $37.70K |
Sep 1999 | $90.40K(+15.9%) | - | - |
Sep 1998 | $78.00K(-13.1%) | - | - |
Sep 1997 | $89.80K | - | - |
FAQ
- What is Arrowhead Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual SGA year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly SGA year-on-year change?
- What is Arrowhead Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals TTM SGA year-on-year change?
What is Arrowhead Pharmaceuticals annual SGA?
The current annual SGA of ARWR is $96.82M
What is the all time high annual SGA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual SGA is $124.43M
What is Arrowhead Pharmaceuticals annual SGA year-on-year change?
Over the past year, ARWR annual SGA has changed by +$5.89M (+6.48%)
What is Arrowhead Pharmaceuticals quarterly SGA?
The current quarterly SGA of ARWR is $27.89M
What is the all time high quarterly SGA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly SGA is $38.29M
What is Arrowhead Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ARWR quarterly SGA has changed by +$3.25M (+13.19%)
What is Arrowhead Pharmaceuticals TTM SGA?
The current TTM SGA of ARWR is -$6.31B
What is the all time high TTM SGA for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high TTM SGA is -$1.99M
What is Arrowhead Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ARWR TTM SGA has changed by -$6.40B (-6713.42%)